What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Enterprise Value?

Reviva Pharmaceuticals Holdings, Inc. Common Stock's Enterprise Value is -$12.7M, based on as-reported figures from SEC (XBRL) filings.

What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM)?

Reviva Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM) is -$13.0M, based on as-reported figures from SEC (XBRL) filings.

What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM)?

Reviva Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM) is -0.99, based on as-reported figures from SEC (XBRL) filings.

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) Financial Statements

Reviva Pharmaceuticals Holdings, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00LJZ8FX7

XNAS · usd

0.54▲ 0.01 (1.60%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.53

Day's Range0.50 – 0.56

52-Week Range0.17 – 3.52

Volume12.1K

Avg Volume560.3K

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed2020-12-15

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)

What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Market Cap?: Reviva Pharmaceuticals Holdings, Inc. Common Stock's Market Cap is $7.1M, based on as-reported figures from SEC (XBRL) filings.
What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Enterprise Value?: Reviva Pharmaceuticals Holdings, Inc. Common Stock's Enterprise Value is -$12.7M, based on as-reported figures from SEC (XBRL) filings.
What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM)?: Reviva Pharmaceuticals Holdings, Inc. Common Stock's Net Income (TTM) is -$13.0M, based on as-reported figures from SEC (XBRL) filings.
What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM)?: Reviva Pharmaceuticals Holdings, Inc. Common Stock's Diluted EPS (TTM) is -0.99, based on as-reported figures from SEC (XBRL) filings.
What is Reviva Pharmaceuticals Holdings, Inc. Common Stock's Net Debt?: Reviva Pharmaceuticals Holdings, Inc. Common Stock's Net Debt is -$19.7M, based on as-reported figures from SEC (XBRL) filings.